12 Documentation Gaps That Commonly Delay US and Canadian Market Entry—And How to Close Them Fast

Missed documentation in eCTD dossiers, QMS, clinical evidence, and labeling often delays FDA and Health Canada approvals. Targeted gap analysis and streamlined dossier authoring can accelerate US and Canadian market…